EUVIMED · CrossrefJournal
Brain Tumor Pathology
ISSN 1433-7398 · Springer Science and Business Media LLC
Latest articles
A pediatric central nervous system tumor with BCOR internal tandem duplication confirmed after initially inconclusive targeted molecular testing: a case report
A case of infant-type hemispheric glioma, ALK-altered, with a 23-year long-term follow-up
Association between PLVAP downregulation and increased lymphocyte infiltration in newly diagnosed glioblastoma treated with bevacizumab
Ependymoma-like tumor with mesenchymal differentiation harboring ZFTA::NCOA2 fusion: a case report
Correction: Comparative molecular profiles of distinct tumor components in recurrent tentorial meningioma after stereotactic radiosurgery: a case report implicating acquired aggressive alterations associated with WHO grade progression
Rapid immunohistochemistry for intraoperative differentiation between high-grade gliomas and primary central nervous system lymphomas: a multicenter prospective study
Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype, of the adult cerebellum: a report of 2 cases
Spinal EWSR1::CREM fused mesenchymal tumor: an extracranial CNS counterpart of intracranial mesenchymal tumor, FET::CREB‑fusion positive
Gliosarcoma of the craniovertebral junction with loss of H3K27me3: a case report with molecular profiling
Dual TERT promoter mutations in glioblastoma, IDH-wildtype: a case report with preclinical investigations
Case report of a rare TCF3::BEND2-fused primary intracranial neuroepithelial neoplasm in a female child
Tectal glioma with pilocytic astrocytoma morphology carrying a histone H3 K27M mutation and malignant transformation: a literature review
Biphasic high-grade cerebellar glioma with epithelial-like components: challenges in integrated diagnosis imposed by limited sampling
Prognostic significance of CDKN2A/B hemizygous deletion in IDH-mutant astrocytomas: a systematic review and meta-analysis
Molecular analysis of a gliosarcoma with distinct oligodendroglioma and sarcomatous components (“Oligosarcoma”)
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy
Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation
High-grade neuroepithelial tumor with EP300::BCOR fusion and negative BCOR immunohistochemical expression: a case report
A novel YAP1-MAML2 fusion in an adult supra-tentorial ependymoma, YAP1-fused
Aggressive nonfunctioning pituitary neuroendocrine tumors
Diffusely infiltrating glioma with CREBBP–BCORL1 fusion showing overexpression of not only BCORL1 but BCOR: A case report
Emerging glioneuronal and neuronal tumors: case-based review
The 2021 WHO classification of tumors, 5th edition, central nervous system tumors: the 10 basic principles
Revisiting vimentin: a negative surrogate marker of molecularly defined oligodendroglioma in adult type diffuse glioma
Two cases of primary supratentorial intracranial rhabdomyosarcoma with DICER1 mutation which may belong to a “spindle cell sarcoma with rhabdomyosarcoma-like feature, DICER1 mutant”
Practical procedures for the integrated diagnosis of astrocytic and oligodendroglial tumors
Radiological characteristics based on isocitrate dehydrogenase mutations and 1p/19q codeletion in grade II and III gliomas
New WHO classification of pituitary adenomas (4th edition): assessment of pituitary transcription factors and the prognostic histological factors
Welcoming the new WHO classification of pituitary tumors 2017: revolution in TTF-1-positive posterior pituitary tumors
Downregulation of SMARCB1/INI1 expression in pediatric chordomas correlates with upregulation of miR-671-5p and miR-193a-5p expressions
EUVIMED